RLAY CIK: 1812364

Relay Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−365
FY22:
−299
FY23:
−373
FY24:
−372
FY25:
−303
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−299
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−276
(positive)
Change from FY21 to FY25
millions USD
FY21:
−364
FY22:
−291
FY23:
−342
FY24:
−338
FY25:
−276

All amounts in millions USD Data sources:SEC EDGARTwelve Data